DI
HRTX icon

DDFG Inc’s Heron Therapeutics HRTX Stock Holding History

DDFG Inc’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.3K Hold
32,903
– – ﹤0.01% 88
2026
Q2 		$14K Buy
+32,903
New +$26.4K ﹤0.01% 92

Other funds holding HRTX

Congress Park Capital
Congress Park Capital Saratoga Springs, New York $381M AUM 20.14% 1-Year Est. Return
Apeiron RIA
Apeiron RIA Dallas, Texas $440M AUM 15.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Redwood Family Wealth
Redwood Family Wealth Addison, Texas $113M AUM 24.54% 1-Year Est. Return
DLK Investment Management
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
New Harbor Financial Group
New Harbor Financial Group Worcester, Massachusetts $669M AUM 22.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

DDFG Inc's HRTX Position: Q3 2026 in Review

DDFG Inc held its Heron Therapeutics (HRTX) position steady in Q3 2026 at 32,903 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #88.

DDFG Inc first reported a position in HRTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $14K in Q2 2026. 36 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • DDFG Inc held 32,903 shares of Heron Therapeutics worth $10.3K as of Q3 2026.
  • DDFG Inc left its Heron Therapeutics share count unchanged in Q3 2026.
  • Heron Therapeutics made up ﹤0.01% of DDFG Inc's portfolio in Q3 2026, its #88 holding.
  • DDFG Inc first reported a position in Heron Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • DDFG Inc's Heron Therapeutics position peaked at $14K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on DDFG Inc's 13F filing for Q3 2026, filed 15 Oct 2026.